Patents Assigned to Benitec, Inc.
  • Patent number: 8993530
    Abstract: The present invention provides compositions and methods suitable for expressing 1-x RNAi agents against a gene or genes in cells, tissues or organs of interest in vitro and in vivo so as to treat diseases or disorders.
    Type: Grant
    Filed: November 10, 2011
    Date of Patent: March 31, 2015
    Assignee: Benitec, Inc.
    Inventors: Petrus W. Roelvink, David A. Suhy, Alexander A. Kolykhalov, Linda Couto
  • Patent number: 8691967
    Abstract: The present invention provides multiple-promoter expression cassettes for simultaneous delivery of RNAi, preferably to mammalian cells in vivo.
    Type: Grant
    Filed: September 26, 2012
    Date of Patent: April 8, 2014
    Assignee: Benitec, Inc.
    Inventors: Petrus W. Roelvink, David A. Suhy, Alexander A. Kolykhalov
  • Publication number: 20130171726
    Abstract: The present invention provides multiple-promoter expression cassettes for simultaneous delivery of RNAi, preferably to mammalian cells in vivo.
    Type: Application
    Filed: September 26, 2012
    Publication date: July 4, 2013
    Applicant: Benitec, Inc.
    Inventor: Benitec, Inc.
  • Patent number: 8283461
    Abstract: The present invention provides multiple-promoter expression cassettes for simultaneous delivery of RNAi, preferably to mammalian cells in vivo.
    Type: Grant
    Filed: March 12, 2010
    Date of Patent: October 9, 2012
    Assignee: Benitec, Inc.
    Inventors: Petrus W. Roelvink, David A. Suhy, Alexander A. Kolykhalov
  • Publication number: 20120058555
    Abstract: The present invention provides compositions and methods suitable for expressing 1-x RNAi agents against a gene or genes in cells, tissues or organs of interest in vitro and in vivo so as to treat diseases or disorders.
    Type: Application
    Filed: November 10, 2011
    Publication date: March 8, 2012
    Applicant: Benitec, Inc.
    Inventors: Petrus W. Roelvink, David A. Suhy, Alexander A. Kolykhalov, Linda Couto
  • Patent number: 8076471
    Abstract: The present invention provides compositions and methods suitable for expressing 1-x RNAi agents against a gene or genes in cells, tissues or organs of interest in vitro and in vivo so as to treat diseases or disorders.
    Type: Grant
    Filed: February 3, 2006
    Date of Patent: December 13, 2011
    Assignee: Benitec, Inc.
    Inventors: Petrus W. Roelvink, David A. Suhy, Alexander A. Kolykhalov, Linda Couto
  • Patent number: 8008468
    Abstract: The present invention provides compositions and methods suitable for RNAi specifically in the liver so as to treat diseases or disorders.
    Type: Grant
    Filed: February 16, 2006
    Date of Patent: August 30, 2011
    Assignee: Benitec, Inc.
    Inventors: Petrus W. Roelvink, David A. Suhy, Alexander A. Kolykhalov, Mark A. Kay, Jeffery C. Giering
  • Publication number: 20110003378
    Abstract: The present invention provides multiple-promoter expression cassettes for simultaneous delivery of RNAi, preferably to mammalian cells in vivo.
    Type: Application
    Filed: March 12, 2010
    Publication date: January 6, 2011
    Applicant: BENITEC, INC.
    Inventors: PETRUS W. ROELVINK, DAVID A. SUHY, ALEXANDER A. KOLYKHALOV
  • Patent number: 7803611
    Abstract: The present invention provides compositions and methods suitable for expressing 1-x RNAi agents against a gene or genes in cells, tissues or organs of interest in vitro and in vivo so as to treat diseases or disorders.
    Type: Grant
    Filed: February 3, 2006
    Date of Patent: September 28, 2010
    Assignee: Benitec, Inc.
    Inventors: Petrus W. Roelvink, David A. Suhy, Alexander A. Kolykhalov, Linda Couto
  • Patent number: 7727970
    Abstract: The present invention provides multiple-promoter expression cassettes for simultaneous delivery of RNAi, preferably to mammalian cells in vivo.
    Type: Grant
    Filed: March 4, 2005
    Date of Patent: June 1, 2010
    Assignee: Benitec, Inc.
    Inventors: Petrus W. Roelvink, David A. Suhy, Alexander A. Kolykhalov
  • Publication number: 20100028998
    Abstract: The present invention provides compositions and methods suitable for expressing 1-x RNAi agents against a gene or genes in cells, tissues or organs of interest in vitro and in vivo so as to treat diseases or disorders.
    Type: Application
    Filed: February 3, 2006
    Publication date: February 4, 2010
    Applicant: Benitec, Inc.
    Inventors: Petrus W. Roelvink, David A. Suhy, Alexander A. Kolykhalov, Linda Couto